Cargando…

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli

Fosfomycin has become a therapeutic option in urinary tract infections. Our objective was to evaluate the in vitro activity of fosfomycin against Escherichia coli isolated from urine samples in 2013, 2018 and 2021. We also determined a putative association between fosfomycin resistance and extended-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ríos, Esther, del Carmen López Diaz, María, Culebras, Esther, Rodríguez-Avial, Iciar, Rodríguez-Avial, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618510/ https://www.ncbi.nlm.nih.gov/pubmed/36056943 http://dx.doi.org/10.1007/s00430-022-00749-2

Ejemplares similares

Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
por: Valderrama, María-José, et al.
Publicado: (2020)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
por: Baos, Elvira, et al.
Publicado: (2022)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Utilidad de MALDI-TOF y REP-PCR frente a PFGE para el estudio epidemiológico de Acinetobacter baumannii
por: García-Salguero, Cristina, et al.
Publicado: (2021)

Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin
por: Gupta, Varsha, et al.
Publicado: (2013)

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase–Producing Escherichia coli Urinary Tract Infections in France
por: Paumier, Adeline, et al.
Publicado: (2022)

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan
por: Tseng, Sung-Pin, et al.
Publicado: (2015)

Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study
por: Harada, Kazuki, et al.
Publicado: (2020)

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
por: Rosso-Fernández, Clara, et al.
Publicado: (2015)

Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents
por: Rodríguez-Avial, Iciar, et al.
Publicado: (2023)

Chronic prostatitis caused by extended-spectrum β-lactamase-producing Escherichia coli managed using oral fosfomycin—A case report
por: Almeida, Francisco, et al.
Publicado: (2019)

Studies on Virulence and Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Isolates and Therapeutic Effect of Fosfomycin in Acute Pyelonephritis Mice
por: Zhang, Lingchun, et al.
Publicado: (2022)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases
por: Ruiz del Castillo, Belén, et al.
Publicado: (2013)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model
por: Zykov, Ilya Nikolaevich, et al.
Publicado: (2018)

Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase Type
por: Branger, Catherine, et al.
Publicado: (2005)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

Problemas de resistencia de materiales
por: Rodríguez-Avial Azcúnaga, Fernando
Publicado: (1976)

Construcciones metálicas
por: Rodríguez-Avial Azcúnaga, Fernando
Publicado: (1968)

Extended-Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Johnson, James R.
Publicado: (2011)

Extended Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Tschudin-Sutter, Sarah, et al.
Publicado: (2010)

The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China
por: Liu, Haihong, et al.
Publicado: (2015)

Extended spectrum beta lactamase producing Escherichia coli tricuspid valve endocarditis
por: Waked, Rami, et al.
Publicado: (2020)

Epidemiological Dynamics of Extended-Spectrum β-Lactamase- or AmpC β-Lactamase-Producing Escherichia coli Screened in Apparently Healthy Chickens in Uganda
por: Kakooza, Steven, et al.
Publicado: (2021)

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Esteve-Palau, Erika, et al.
Publicado: (2018)

Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: TÜZÜN, Türkan, et al.
Publicado: (2019)

Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens
por: Banerjee, Sayantan, et al.
Publicado: (2017)

Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains
por: Yeganeh-Sefidan, Fatemeh, et al.
Publicado: (2016)

Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2012)

Description of carbapenemase-producing Enterobacteriaceae isolates in a Spanish tertiary hospital. Epidemiological analysis and clinical impact
por: López-González, Laura, et al.
Publicado: (2019)

A Case of Postoperative Endophthalmitis by Extended-spectrum Beta-lactamase-producing Escherichia coli
por: Kim, Yu Cheol, et al.
Publicado: (2012)

Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands
por: Overdevest, Ilse, et al.
Publicado: (2011)

Extended spectrum beta-lactamases detected in Escherichia coli from gulls in Stockholm, Sweden
por: Wallensten, Anders, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dk0sm02fv6a4t8ji2v2t5jbvnr